iifl-logo

Nippon India Nifty Pharma ETF

Nippon India Nifty Pharma ETF

Fund Name

Nippon India Mutual Fund

Scheme Name

Nippon India Nifty Pharma ETF

AMC

Nippon India Mutual Fund

Type

:  Open

Category

Exchange Traded Funds (ETFs)

Launch Date

21-Jun-2021

Fund Manager

Jitendra Tolani

Net Assets (Rs. cr)

887.84

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Nippon India Nifty Pharma ETF - Nav Details

Nav Date

:  19-May-2025

NAV [Rs.]

:  22.1894

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

Nil

Nippon India Nifty Pharma ETF- NAV Chart

Nippon India Nifty Pharma ETF- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
3.01
2.89
4.37
-
14.97
20.53
-
11.79
Category Avg
5.09
6.8
8.56
4.08
9.95
20.12
24.9
15.58
Category Best
17.16
26.06
53.11
37.78
33.77
43.89
41.52
453.29
Category Worst
-1.24
-2.3
-8.02
-9.91
-7.98
7.51
4.6
-26.07

Nippon India Nifty Pharma ETF- Latest Dividends

No Records Found

Nippon India Nifty Pharma ETF- Investment Details

Min. Investment(Rs.)

1000

Increm.Investment(Rs.)

0

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology25.531237230226.69
EquityCiplaPharmaceuticals & Biotechnology11.27645572100.07
EquityDivi's Lab.Pharmaceuticals & Biotechnology9.9914572088.69
EquityDr Reddy's LabsPharmaceuticals & Biotechnology9.3370000282.87
EquityLupinPharmaceuticals & Biotechnology6.5427717658.08
EquityTorrent Pharma.Pharmaceuticals & Biotechnology4.4912002439.87
EquityAurobindo PharmaPharmaceuticals & Biotechnology4.4432093239.44
EquityMankind PharmaPharmaceuticals & Biotechnology3.6012959631.94
EquityAlkem LabPharmaceuticals & Biotechnology3.516097231.19
EquityLaurus LabsPharmaceuticals & Biotechnology3.0544909427.11
EquityZydus Lifesci.Pharmaceuticals & Biotechnology2.8728662925.45
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology2.6917276923.86
EquityIpca Labs.Pharmaceuticals & Biotechnology2.5215946822.34
EquityAbbott IndiaPharmaceuticals & Biotechnology2.02598017.93
EquityBioconPharmaceuticals & Biotechnology1.8751679416.63
EquityJ B Chemicals &Pharmaceuticals & Biotechnology1.498229413.26
EquityAjanta PharmaPharmaceuticals & Biotechnology1.474833313.07
EquityGland PharmaPharmaceuticals & Biotechnology1.449131312.78
EquityNatco PharmaPharmaceuticals & Biotechnology0.981026918.73
EquityGranules IndiaPharmaceuticals & Biotechnology0.851662887.57
Cash & Cash Equivalent
Reverse RepoTREPS-/-0.0400.35
Net CA & OthersNet CA & Others-/-0.010-0.19
Cash & Cash EquivalentC C I-/-0.0000.00

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
5,61,387.15
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart

OTHER INFORMATION

Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.